U.S. Physical Therapy, Inc. (USPH)
NYSE: USPH · Real-Time Price · USD
71.93
-1.13 (-1.55%)
At close: Mar 28, 2025, 4:00 PM
68.94
-2.99 (-4.16%)
After-hours: Mar 28, 2025, 8:00 PM EDT
U.S. Physical Therapy Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for U.S. Physical Therapy stock have an average target of 109, with a low estimate of 98 and a high estimate of 115. The average target predicts an increase of 51.54% from the current stock price of 71.93.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for U.S. Physical Therapy stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $120 → $110 | Buy | Maintains | $120 → $110 | +52.93% | Mar 19, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $108 → $98 | Buy | Maintains | $108 → $98 | +36.24% | Feb 28, 2025 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $100 → $115 | Hold → Strong Buy | Upgrades | $100 → $115 | +59.88% | Dec 16, 2024 |
| JMP Securities | JMP Securities | Buy Initiates $113 | Buy | Initiates | $113 | +57.10% | Dec 16, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $117 → $120 | Buy | Maintains | $117 → $120 | +66.83% | Dec 3, 2024 |
Financial Forecast
Revenue This Year
757.43M
from 664.43M
Increased by 14.00%
Revenue Next Year
805.85M
from 757.43M
Increased by 6.39%
EPS This Year
2.70
from 1.84
Increased by 46.57%
EPS Next Year
3.02
from 2.70
Increased by 12.10%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 811.9M | 872.6M | 939.7M |
| Avg | 757.4M | 805.9M | 912.8M |
| Low | 716.2M | 761.5M | 877.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 22.2% | 15.2% | 16.6% |
| Avg | 14.0% | 6.4% | 13.3% |
| Low | 7.8% | 0.5% | 8.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.36 | 3.91 | 3.26 |
| Avg | 2.70 | 3.02 | 3.16 |
| Low | 2.13 | 2.36 | 3.04 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 82.5% | 44.8% | 7.6% |
| Avg | 46.6% | 12.1% | 4.6% |
| Low | 15.5% | -12.5% | 0.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.